PuSH - Publication Server of Helmholtz Zentrum München

178 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Baran-Marszak, F.* et al.: Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 104, 2475-2483 (2004)
Massberg, S.* et al.: Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)-deficient mice. Blood 103, 136-142 (2004)
Pfister, H.* et al.: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 104, 1411-1418 (2004)
Specht, K. et al.: Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 104, 1120-1126 (2004)
Katzenberger, T.* et al.: Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell. Blood 101, 699-702 (2003)
Kolb, H.-J. ; Schmid, C. ; Barrett, A.J.* & Schendel, D.J.: Graft-versus-leukemia reactions in allogeneic chimeras. Blood 103, 767-776 (2003)
Quintanilla-Martinez, L. et al.: Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL) : Implications for pathogenesis. Blood 101, 3181-3187 (2003)
Schuster, C.* et al.: The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate. Blood 101, 655-663 (2003)
Warmuth, M. et al.: Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate-resistant Bcr-Abl kinases. Blood 101, 664-672 (2003)
Kronenberger, K. et al.: Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells. Blood 99, 1327-1331 (2002)
Moosmann, A.* et al.: B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactive specific cytotoxic T cells. Blood 100, 1755-1764 (2002)
Spiekermann, K. et al.: A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia. Blood 100, 3423-3425 (2002)
Wendtner, C.-M. et al.: Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno- associated virus (rAAV) vectors. Blood 100, 1655-1661 (2002)
Plötz, S.G.* et al.: The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood 97, 235--241 (2001)
Ruf, P. & Lindhofer, H.G.: Induction of a long-lasting antitumor immunity by a trifunctional bispecific antibody. Blood 98, 2526-2534 (2001)
Ascherl, G.* et al.: Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T-cells: Implications for acquired immunodeficiency syndrome-associated vasculopathy. Blood 93, 4232-4241 (1999)
Drzeniek, Z.* et al.: Heparan sulfate proteoglycan expression is induced during early erythroid differentiation of multipotent hematopoietic stem cells. Blood 93, 2884-2897 (1999)
Ertel, W.* et al.: Inhibition of the defense system stimulating interleukin-12 interferon-γ pathway during critical illness. Blood 89, 1612-1620 (1997)
Zeidler, R. et al.: Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10. Blood 90, 2390-2397 (1997)
Ertel, W.* et al.: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85, 1341-1347 (1995)